Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Angew Chem Int Ed Engl ; 60(26): 14355-14359, 2021 06 21.
Article in English | MEDLINE | ID: mdl-33847459

ABSTRACT

Quinazolinones are common substructures in molecules of medicinal importance. We report an enantioselective copper-catalyzed borylative cyclization for the assembly of privileged pyrroloquinazolinone motifs. The reaction proceeds with high enantio- and diastereocontrol, and can deliver products containing quaternary stereocenters. The utility of the products is demonstrated through further manipulations.

2.
Angew Chem Int Ed Engl ; 59(46): 20278-20289, 2020 11 09.
Article in English | MEDLINE | ID: mdl-32544295

ABSTRACT

Copper-catalyzed borylative multicomponent reactions (MCRs) involving olefins and C-N electrophiles are a powerful tool to rapidly build up molecular complexity. The products from these reactions contain multiple functionalities, such as amino, cyano and boronate groups, that are ubiquitous in medicinal and process chemistry programs. Copper-catalyzed MCRs are particularly attractive because they use a relatively abundant and non-toxic catalyst to selectively deliver high-value products from simple feedstocks such as olefins. In this Minireview, we explore this rapidly emerging field and survey the borylative union of allenes, dienes, styrenes and other olefins, with imines, nitriles and related C-N electrophiles.

3.
Med Sci Monit ; 24: 5904, 2018 08 24.
Article in English | MEDLINE | ID: mdl-30142144

ABSTRACT

In the article entitled, "Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)", which was published in Medical Science Monitor 2017-04-23, Med Sci Monit 2017; 23: 1947-1955, the text has been directly copied from a previously published article entitled, "Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in thyrotropin-secreting pituitary adenomas: a consecutive case series of pituitary adenomas" by Hong-Juan Fang, Yang-Fang Li, Yu Fu, Li-Yong Zhong, and Ya-Zhuo Zhan in Int J Clin Exp Pathol 2017;10(1): 479-488 (www.ijcep.com /ISSN: 1936-2625/IJCEP0042895). Thus, owing to the duplicity of text, the article is being retracted.

4.
Med Sci Monit ; 23: 1947-1955, 2017 Apr 23.
Article in English | MEDLINE | ID: mdl-28434012

ABSTRACT

BACKGROUND Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare cause of hyperthyroidism. Somatostatin analogs have proved to be effective for inhibiting pituitary hormones secretion, working via interactions with somatostatin receptors (SSTRs). Moreover, antiproliferative activity of somatostatin analog is now demonstrated in several studies. In the present study, we determined the relative predominance of SSTR2 and SSTR5 subtypes among the different types of adenomas, especially TSHoma, and investigated the relationship between efficacy of short-term octreotide (OCT) treatment and SSTR expression. MATERIAL AND METHODS Serum hormone determinations and histological findings in resected tissue resulted in 5 diagnoses: 16 TSHomas, 8 acromegaly, 3 prolactinomas, 3 corticotropinomas, 4 clinically nonfunctioning adenomas (NFPAs), and 4 normal pituitary specimens. IHC was performed on formalin-fixed and paraffin-embedded tissue in tissue microarrays. RESULTS IHC of SSTR subtypes in the different cohorts showed SSTR2 staining intensity scores higher than SSTR5 in TSHoma, acromegaly and prolactinoma, whereas the expression of SSTR5 was stronger than SSTR2 in corticotropinoma and NFPA. SSTR2 and SSTR5 expressions were significantly higher in TSHoma than in other pituitary adenomas. OCT treatment for a median of 8.4 days (range: 3-18 days) and with a total median dose of 1.9 mg (range: 0.9-4.2 mg) showed a significant decrease of thyroid hormone levels (TSH [µIU/ml] in all patients. Patients with low SSTR5 expression presented a significantly higher TSH suppression rate (P values <0.05). CONCLUSIONS The present data confirm that somatostatin analogs should be considered as a medical alternative to surgical treatment, especially in patients with TSHoma, and short-term response to OCT therapy may be related to the expression of SSTR5.


Subject(s)
Receptors, Somatostatin/genetics , Adolescent , Adult , Aged , Female , Humans , Hyperthyroidism/genetics , Hyperthyroidism/metabolism , Hyperthyroidism/pathology , Male , Middle Aged , Pituitary Neoplasms/genetics , Pituitary Neoplasms/metabolism , Pituitary Neoplasms/pathology , RNA, Messenger/metabolism , Receptors, Somatostatin/metabolism , Receptors, Somatostatin/physiology , Somatostatin/genetics , Somatostatin/metabolism , Thyrotropin/genetics , Thyrotropin/metabolism
5.
Aging (Albany NY) ; 13(14): 18298-18309, 2021 07 29.
Article in English | MEDLINE | ID: mdl-34325402

ABSTRACT

NudC domain containing 1 (NUDCD1) is an oncoprotein frequently activated or upregulated in various human cancers, but its role in pancreatic cancer (PC) remains unknown. Thus, we aimed to determine the function and mechanism of NUDCD1 in PC. We employed Western blot and quantitative real-time polymerase chain reaction to assess NUDCD1 expression in cells and PC tissues. NUDCD1 was knocked down in Patu8988 and PANC-1 cells. We conducted real-time cell analysis, wound healing assay, transwell assay and colony formation assay to evaluate the metastatic and proliferative abilities of PC cells. Western blot was conducted to assess the expression of markers associated with apoptosis and epithelial-mesenchymal transition (EMT). Also, we established a tumor xenograft model to determine the role of NUDCD1 in vivo. NUDCD1 was overexpressed in PC tissues and cells. NUDCD1 knockdown suppressed the invasion, migration, and proliferative abilities of the cells and induced PC cell apoptosis. The specific mechanism of NUDCD1 was related to the modulation of the EMT process. Data obtained from in vivo experiments revealed that NUDCD1 knockdown inhibited the tumor growth, proliferation, and metastasis by modulating the EMT and inducing the apoptosis of PC cells.


Subject(s)
Antigens, Neoplasm/metabolism , Epithelial-Mesenchymal Transition , Pancreas , Pancreatic Neoplasms/metabolism , Animals , Antigens, Neoplasm/genetics , Apoptosis , Cell Line, Tumor , Cell Movement , Cell Proliferation , Gene Expression Regulation, Neoplastic , Humans , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness , Pancreas/metabolism , Pancreas/pathology , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Xenograft Model Antitumor Assays , Pancreatic Neoplasms
6.
J Comb Chem ; 12(4): 430-4, 2010 Jul 12.
Article in English | MEDLINE | ID: mdl-20503973

ABSTRACT

A series of 4-aza-podophyllotoxin derivatives have been synthesized regioselectively via the three-component reaction of aldehydes, aromatic amines, and tetronic acid catalyzed by l-proline. This method has the advantages of high yield, high regioselectivity, extensive adaptability, easy operation, and environmental friendliness. These compounds were also investigated in vitro, and some were found to have good anticancer activity.


Subject(s)
Antineoplastic Agents/chemical synthesis , Aza Compounds/chemical synthesis , Podophyllotoxin/chemical synthesis , Proline/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Aza Compounds/chemistry , Aza Compounds/pharmacology , Catalysis , Cell Line, Tumor , Cell Proliferation/drug effects , Crystallography, X-Ray , Drug Screening Assays, Antitumor , Humans , Models, Molecular , Molecular Structure , Podophyllotoxin/chemistry , Podophyllotoxin/pharmacology , Stereoisomerism
7.
J Comb Chem ; 12(2): 231-7, 2010 Mar 08.
Article in English | MEDLINE | ID: mdl-20085353

ABSTRACT

An efficient one-pot synthesis of spirooxindole derivatives by three-component reaction of isatins, malononitrile (cyanoacetic ester) and 1,3-dicarbonyl compounds in water in the presence of l-proline is reported. This new protocol has the advantages of environmental friendliness, higher yields, shorter reaction times, low cost, and convenient operation.


Subject(s)
Indoles/chemical synthesis , Proline/chemistry , Spiro Compounds/chemical synthesis , Catalysis , Water
8.
Acta Crystallogr Sect E Struct Rep Online ; 66(Pt 3): o668, 2010 Feb 20.
Article in English | MEDLINE | ID: mdl-21580416

ABSTRACT

In the title compound, C(22)H(17)NO(2), the fused ring system is essentially planar (r.m.s. deviation = 0.021 Å) and the dihedral angle between the dihydro-pyridine and tolyl rings is 80.98 (11)°. In the crystal, the mol-ecules are linked into chains along the b axis by inter-molecular N-H⋯O and C-H⋯O hydrogen bonds. Adjacent chains are linked by π-π inter-actions [centroid-centroid separation = 3.5748 (15) Å].

9.
FEBS Open Bio ; 10(11): 2404-2416, 2020 11.
Article in English | MEDLINE | ID: mdl-33010109

ABSTRACT

Fluorosis is a common disease characterized by disruptions in bone metabolism and enamel development. The production of reactive oxygen species is thought to play an important role in fluorosis. Gastrodin (4-hydroxybenzylalcohol4-O-beta-D-glucopyranoside) has been reported to have antioxidative activity, and so here we examined whether gastrodin has protective effects against oxidative stress and bone tissue toxicity in rats with fluorosis. Wistar rats were given different doses of gastrodin 1 month after fluoride administration, and samples of blood, bone and teeth were collected after 2, 3 and 4 months; glutathione peroxidase glu, CAT and SOD levels in the fluorosis group were lower than those in the control group. Gastrodin treatment in rats ameliorated oxidative stress and fluoride accumulation that were induced by fluoride; treatment with 400 mg·kg-1 gastrodin protected trabecular bone structure and reduced femur and alveolar bone injury in rats with fluorosis. Enhanced expression of cysteinyl aspartate-specific proteinase (caspase) 3, caspase-9 and Bax and decreased expression of Bcl-2 induced by fluoride were also reversed by gastrodin. In summary, the present data suggest that gastrodin, and in particular a dose of 400 mg·kg-1 , can improve the antioxidative capacity of rats, reduce concentration of fluoride in tissues, alleviate bone damage and modulate expression of Bcl-2, Bax, caspase-3 and caspase-9.


Subject(s)
Benzyl Alcohols/pharmacology , Bone and Bones/metabolism , Glucosides/pharmacology , Proteins/metabolism , Animals , Apoptosis/drug effects , Bone and Bones/drug effects , Cancellous Bone/drug effects , Cancellous Bone/pathology , Cell Line , Cell Proliferation/drug effects , Chronic Disease , Femur/drug effects , Femur/pathology , Fluorides/blood , Fluorides/metabolism , Fluorosis, Dental/blood , Fluorosis, Dental/pathology , Humans , Male , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Rats, Wistar
10.
Int J Nanomedicine ; 15: 8983-8998, 2020.
Article in English | MEDLINE | ID: mdl-33239873

ABSTRACT

BACKGROUND: Relying on surface topography alone to enhance the osteointegration of implants is still inadequate. An effective way to combine long-term ion release and surface topography to enhance osteogenic property is urgently needed. PURPOSE: The objective of this study is to fabricate a long-term strontium ion release implant system and confirm the biological function in vitro and in vivo. METHODS: The biomimic surface was fabricated through alkali-heat treatment and magnetron sputtering. The in vitro biological function assays were determined by MTT, fluorescence staining, alkaline phosphatase activity, extracellular mineralization, and quantitative real-time polymerase chain reaction assays. The in vivo experiments were detected by micro-CT, HE staining and Masson staining. RESULTS: The biomimic surface structure has been successfully fabricated. The in vitro cell assays determined that AH-Ti/Sr90 possessed the best biological function. The in vivo experiments demonstrated that AH-Ti/Sr90 could promote osteointegration significantly under both in normal and osteoporotic conditions. CONCLUSION: We determined that AH-Ti/Sr90 possesses the best osteogenic property, long-term ion release capacity and osteointegration promotion ability. It has potential clinic application prospects.


Subject(s)
Nanostructures/chemistry , Osseointegration , Prostheses and Implants , Strontium/chemistry , Animals , Bone-Implant Interface , Cell Line , Female , Gene Expression Regulation , Mice , Osseointegration/drug effects , Osteogenesis/genetics , Osteoporosis/etiology , Rats, Sprague-Dawley , Skull/cytology , Surface Properties , Titanium/chemistry , X-Ray Microtomography
11.
J Mater Chem B ; 7(37): 5677-5687, 2019 10 07.
Article in English | MEDLINE | ID: mdl-31475273

ABSTRACT

Poly(phosphoester)-based biomaterials have great potential in drug delivery systems (DDSs) because of their multifunctional adjustability, stealth effect, excellent biodegradability, and biocompatibility. To further increase the drug loading efficiency (DLE) and sustained release ability, a multi-arm block copolymer, poly(amido amine)-b-poly(2-butenyl phospholane)-b-poly(2-methoxy phospholane) conjugated with folic acid (abbreviated as PAMAM-PBEP-PMP-FA), was designed and prepared. Compared to the traditional linear copolymers, this multi-arm phosphoester block copolymer integrates a balanced combination of unique features. As an advanced DDS, the PAMAM-PBEP-PMP-FA based supramolecular micelle provides good architectural stability, low protein adsorption, extremely high DLE, and sustained drug release for chemotherapy and abundant surface chemistry for target engineering. Benefitting from these novel functions, the supramolecular micellar drug delivery system exhibits great performances both in in vitro and in vivo evaluations. Doxorubicin (DOX)-loaded supramolecular micelles PAMAM-PBEP-PMP-FA/DOX are fast taken up by HepG2 cells and inhibit the tumor growth effectively in HepG2-tumor-bearing nude mice without obvious system toxicity. This work not only suggests a targeted sustained release DDS for effective chemotherapy but also enlightens, through a delicate design at the molecular scale, the brilliance of multifunctional PPE-based nanomaterials towards versatile bio-applications.


Subject(s)
Carcinogenesis/drug effects , Delayed-Action Preparations/chemistry , Neoplasms/drug therapy , Animals , Cell Survival , Doxorubicin/administration & dosage , Hep G2 Cells , Humans , Mice , Mice, Nude , Micelles , Polymers/chemistry , Xenograft Model Antitumor Assays
12.
J Comb Chem ; 10(6): 810-3, 2008.
Article in English | MEDLINE | ID: mdl-18729409

ABSTRACT

1,2,3,5-Tetrasubstituted and 1,2,3,4,5-pentasubstituted pyrroles may be synthesized through three-component reaction of 1,3-diketones, aldehydes, and amines induced by low-valent titanium reagent. High regioselectivity was achieved. Compared with the classical synthetic method, this new method has the advantages of short reaction time (15 min), high yields, convenient manipulation, and high regioselectivity.


Subject(s)
Combinatorial Chemistry Techniques/methods , Pyrroles/chemical synthesis , Titanium/chemistry , Aldehydes/chemistry , Amines/chemistry , Indicators and Reagents , Ketones/chemistry
13.
Acta Crystallogr Sect E Struct Rep Online ; 65(Pt 1): o100, 2008 Dec 13.
Article in English | MEDLINE | ID: mdl-21581564

ABSTRACT

In the title compound, C(19)H(17)NO(2), the dihydro-pyridine ring adopts a flattened boat conformation while the furan-one ring is almost planar (r.m.s. deviation 0.018 Å). The mol-ecules are linked into chains along the b axis by N-H⋯O inter-molecular hydrogen bonds. In addition, C-H⋯π inter-actions involving the phenyl ring of the tolyl group as π acceptor are observed.

14.
Oncol Lett ; 15(6): 8303-8310, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29928320

ABSTRACT

Osteosarcoma (OS) is identified as the most commonly diagnosed malignant cancer of bone, and has approximately three million new cases annually. miR-26a plays an important role in the development of various types of cancer. We investigated whether miR-26a can regulate the migration and invasion of OS by targeting high-mobility group A1 HMGA1. Western blot analysis was used to identify the changes of protein levels. Reverse transcription-quantitative PCR was used to test expression levels of genes and miR-26a. Luciferase reporter assay was used to test the specific target gene of miR-26a. Transwell assay was employed to determine the migration and invasion of OS cell lines. In the present study, miRNA-26a was frequently downregulated in OS tissues and cells. Overexpression of miR-26a inhibited cell migration and invasion in vitro. In addition, miR-26a downregulated HMGA1 by targeting its 3'-UTR and knockdown of HMGA1 significantly suppressed the migration and invasion of two osteosarcoma cell lines in vitro. miR-26a suppressed the migration and invasion of OS cells by targeting HMGA1, suggesting that miR-26a/HMGA1 axis provides a new prospective therapeutic strategy for OS.

15.
Macromol Biosci ; 17(7)2017 07.
Article in English | MEDLINE | ID: mdl-28371385

ABSTRACT

Novel biodegradable polymers with specific properties, structures, and tailorable designs or modifications are in great demand. Poly(phosphoester)s with good biocompatibility and degradability, as well as other adjustable properties have been studied widely because of their potential in biomedical applications. To meet more versatile and diverse biomedical applications, a novel multiarm star-shaped phosphorester triblock copolymer poly(amido amine)-block-poly(2-butynyl phospholane)-block-poly(2-methoxy phospholane) (PAMAM-PBYP-PMP) is synthesized via organo-catalyzed sequential ring-opening polymerization. Supramolecular micelles with good architectural stability are self-assembled into uniform spherical morphology in aqueous solution. Doxorubicin (DOX) can be encapsulated into the micelles with efficient loading capacity. A slow and sustained release in the environment of simulated intracellular lysosome (pH 5.0 with phosphodiesterase I) is observed. In addition, the copolymers and DOX-loaded supramolecular micelles exhibit low cell-toxicity and excellent anticancer activity toward HeLa cells. As a consequence, this multiarm star-shaped PAMAM-PBYP-PMP has great potential in drug delivery system for tumor treatment.


Subject(s)
Dendrimers , Doxorubicin , Drug Carriers , Dendrimers/chemistry , Dendrimers/pharmacology , Doxorubicin/chemistry , Doxorubicin/pharmacology , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Carriers/pharmacology , HeLa Cells , Humans
SELECTION OF CITATIONS
SEARCH DETAIL